Bank of Ann Arbor’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bank of Ann Arbor’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$30.2K	Buy	+300	New	+$30.8K	﹤0.01%	342

Other funds holding IHE

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Foundations Investment Advisors Phoenix, Arizona $10.1B AUM 19.55% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

MML Investors Services Springfield, Massachusetts $32.8B AUM 18.62% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $116B AUM 33.19% 1-Year Est. Return

MinichMacGregor Wealth Management Saratoga Springs, New York $620M AUM 32.35% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Horizon Investments Charlotte, North Carolina $11.6B AUM 26.87% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return

Bank of Ann Arbor's IHE Position: Q3 2026 in Review

Bank of Ann Arbor opened a new position in iShares US Pharmaceuticals ETF (IHE) in Q3 2026: 300 shares worth $30.2K. The stake represents ﹤0.01% of the portfolio and ranks #342 among its holdings.

211 funds tracked by Wall St. Rank hold IHE as of Q3 2026.

Bank of Ann Arbor held 300 shares of iShares US Pharmaceuticals ETF worth $30.2K as of Q3 2026.
iShares US Pharmaceuticals ETF was a new Bank of Ann Arbor position in Q3 2026.
iShares US Pharmaceuticals ETF made up ﹤0.01% of Bank of Ann Arbor's portfolio in Q3 2026, its #342 holding.
211 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2026.

Based on Bank of Ann Arbor's 13F filing for Q3 2026, filed 13 Nov 2026.